Cervical cancer, the most common female cancer in India, is a preventable malignancy. The recent recognition that genital tract infection with high-risk human papillomavirus (HPV) is the primary cause of cervical cancer has led to HPV-based cancer prevention strategies. The proposed project will be carried out in Medchal Mandal, a rural community near Hyderabad, in Andhra Pradesh, India. Its broad objectives are to help identify the optimum cervical cancer screening method for rural India and to evaluate the viral and cellular markers of progression to cancer. It is anticipated that almost all of the approximately 12,000 eligible women in this community (30 years old or older) will each be screened for cervical cancer with four methods: Pap smear, visual inspection of the cervix, HPV DNA in cervix, and HPV DNA in self-collected swabs. Women with abnormal results in any one or more screens will be colposcoped and biopsied if necessary. Those found to have high-grade lesions or cervical cancer will be treated. Women who have abnormal screens but do not require treatment, as well as women without abnormal screens, will be monitored annually for an additional four years for development of high grade lesions or cervical cancer. It is estimated that more than 200 women with high-grade lesions and about 20-30 women with cervical cancer will be identified during the study period. Appropriate biological specimens will be collected to meet the following specific aims: (a) to compare the four screening methods for their ability to identify prevalent disease and to predict incident disease, (b) to characterize viral genotype, viral variants, viral persistence, viral load and integration for their role in disease progression, (c) to evaluate cellular markers such as p16 over-expression, loss of FHIT expression, gain of chromosome 3q, and altered patterns of methylation for their role in disease progression, and (d) to correlate the viral and cellular markers of disease progression. The detailed investigation of viral and cellular markers of cervical cancer in a community-based population may aid in the establishment of more detailed models of cervical cancer development. Broadly, the integrated observations from this study may help identify screening methods and biological markers that may be valuable for cervical cancer prevention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA098252-01
Application #
6824959
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2003-09-30
Project End
2008-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Boitano, Teresa K L; Smith, Haller J; Rushton, Tullia et al. (2018) Impact of enhanced recovery after surgery (ERAS) protocol on gastrointestinal function in gynecologic oncology patients undergoing laparotomy. Gynecol Oncol 151:282-286
Anchoori, Ravi K; Jiang, Rosie; Peng, Shiwen et al. (2018) Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer. ACS Omega 3:11917-11929
Ooki, Akira; Dinalankara, Wikum; Marchionni, Luigi et al. (2018) Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma. Oncogene 37:5967-5981
Ahn, Julie; Bishop, Justin A; Roden, Richard B S et al. (2018) The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosis. Laryngoscope 128:E27-E32
Silver, Michelle I; Rositch, Anne F; Phelan-Emrick, Darcy F et al. (2018) Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years. Cancer Causes Control 29:43-50
Yang, J-Ming; Bhattacharya, Sayak; West-Foyle, Hoku et al. (2018) Integrating chemical and mechanical signals through dynamic coupling between cellular protrusions and pulsed ERK activation. Nat Commun 9:4673
Xing, Deyin; Zheng, Gang; Schoolmeester, John Kenneth et al. (2018) Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix. Am J Surg Pathol 42:750-760
Qiu, Jin; Peng, Shiwen; Ma, Ying et al. (2018) Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination. Virology 525:205-215
Ooki, Akira; Begum, Asma; Marchionni, Luigi et al. (2018) Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells. Int J Cancer 143:113-126
Leath 3rd, Charles A; Monk, Bradley J (2018) Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years. Gynecol Oncol 150:391-397

Showing the most recent 10 out of 291 publications